SBS — Companhia de Saneamento Básico (SABESP)
Price when we picked it (Jun 8, 2026)
$5.35
Target: $6.84 (+27.9%)
P/E Ratio
11.4
P/E Forward
13.5
Dividend
1.91%
Market Cap
$18.65B
EPS
$0.47
Consensus
Strong Buy
What they do
Companhia de Saneamento Básico do Estado de São Paulo — SABESP (NYSE ADR: SBS; B3: SBSP3) is the water and sanitation company of the state of São Paulo, Brazil. It provides drinking water and wastewater collection/treatment to more than 40 million people — one of the largest water companies in the world.
How it makes money: it's a regulated utility-style service. It charges homes and businesses a monthly rate for two things: the clean water coming in and the dirty water going out (sewage + treatment). Demand is inelastic — people need water rain or shine — which makes revenue very predictable.
The structural turn — the 2024 privatization: for decades it was a slow state-owned company. In July 2024 the state of São Paulo privatized it: it cut its stake from ~50% to 18% and brought in Equatorial (a private utility operator with a strong track record) as the reference shareholder, at R$67/share. The new CEO, Carlos Piani (ex-Equatorial), came in to bring private-sector discipline to a monopoly asset.
The plan: invest R$70 billion to reach 'universalization' — 99% water coverage and 90% sewage coverage — by 2029, moved up from 2033. That's why today's dividend is low (~1.91%): the cash is going into the expansion.
Important note: SABESP did a 1-for-5 split effective May 2026; the ADR trades post-split at ~$5.35 (many search engines still show old prices of ~$25-30). Q1 2026: revenue R$6.0 billion (+10.9%), adjusted profit +32%.
Why we like it
SBS at $5.35 means buying a water monopoly serving 40 million people right as it passed from slow state hands to a private operator with a legal mandate to invest and grow. Specific reasons:
- A monopoly on an essential service: water is the most predictable demand there is — people pay their water bill before almost anything else. SABESP is the only option for 40+ million people in Brazil's richest state.
- A privatization re-rating: this is the core case. A freshly privatized state company tends to become worth more over time, because private management squeezes years of inefficiency out of the system. Equatorial has already done it before with electric utilities.
- A clear investment mandate: R$70 billion to universalize water (99%) and sewage (90%) by 2029. More infrastructure = more billable customers = more regulated revenue.
- Growth already visible: Q1 2026 revenue +10.9% and profit +32% in one year — the thesis is already showing up in the numbers.
- A dividend that will grow: today's ~1.91% is low on purpose (reinvesting); as the investment cycle winds down, the dividend is expected to rise.
- Reasonable valuation: ~11x earnings for a growing regulated monopoly. Analysts: Strong Buy, target ~$6.84 (~+28%).
Key Risk
Risks:
- Regulatory/political — the #1: rates and investment targets are set by a regulator and by law. A hostile political shift in São Paulo (or a future state government) could limit its power to raise rates or increase the mandatory investment burden, hurting returns.
- Brazilian real / FX: the business earns in reais (BRL) but the ADR trades in dollars. If the real weakens, the USD value of the ADR falls even if the company bills the same in local currency. It's the dominant risk of any Brazilian ADR.
- Plan-execution risk: the R$70 billion plan is enormous; if costs balloon or coverage targets slip, the thesis dilutes.
- Leverage: financing that much investment pushes debt up; if Brazilian interest rates rise, the financial cost weighs.
- A single-region company: all the value is tied to São Paulo and Brazil — no geographic diversification.
- A low dividend today (~1.91%): if you're after immediate income, this isn't it — the bet is value growth + a growing future dividend.
This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.
Vectorial Data picked SBS on Jun 8, 2026 at $5.35.
Full Research
SABESP (SBS) — Full Research
Price: $5.35 (post-split) | P/E TTM: ~11.4x | Div Yield: ~1.91% | Market Cap: ~$18.65B USD
⚠️ Split note
SABESP did a 1-for-5 split effective May 2026. The ADR trades post-split at ~$5.35. Old prices of ~$25-30 still showing up in search engines are outdated.
What is SABESP?
The water and sewage company of the state of São Paulo, Brazil. It serves 40+ million people. A near-monopoly on an essential service. NYSE ADR: SBS.
The turn: the 2024 privatization
| Before | After (Jul 2024) |
|---|---|
| State-owned (state held ~50%) | State cut to 18% |
| Slow management | Equatorial enters as private operator (R$67/share) |
| — | New CEO Carlos Piani (ex-Equatorial) |
The plan
- R$70 billion of investment.
- Goal: 99% water coverage + 90% sewage by 2029 (moved up from 2033).
- That's why today's dividend is low: reinvestment.
Q1 2026
| Metric | Q1 2026 | YoY |
|---|---|---|
| Revenue | R$6.0 billion | +10.9% |
| Adjusted profit | — | +32% |
| EBITDA | R$3.8 billion | +26% (63% margin) |
Leadership
- CEO: Carlos Piani (since Oct 2024).
Anchor Fact
Brazil's government just handed the water monopoly serving 40 million people over to private hands — and gave them a legal deadline: bring clean water to 99% and sewage service to 90% of the state of São Paulo by 2029, four years ahead of plan. In its first full quarter under that mandate, profit jumped 32% in a single year. It's a boring company (water) in the middle of a transformation.
Top 5 Risks
- Regulatory/political — rates and investment set by law/regulator
- Brazilian real / FX — earns in reais, ADR in dollars
- Executing the R$70 billion plan
- Leverage — financing the investment pushes debt up
- A single region — everything tied to São Paulo / Brazil
Analyst Consensus
- Rating: Strong Buy
- Average target: ~$6.84 (~+28% from $5.35)
The Thesis in One Line
The water monopoly for 40 million people, freshly privatized and under a legal mandate to invest and grow — a classic state-to-private re-rating, with a dividend set to grow.
Research date: Jun 8, 2026 | Next review: Dec 2026
This is not financial advice.
This is not financial advice. Consult a certified financial advisor.
The author may hold positions in the securities discussed.
Past performance does not guarantee future results.